No abstract

Objective. To identify the main causes of nosocomial measles outbreaks and factors that caused stable secondary transmission of this infection in healthcare institutions. Materials and methods. We analyzed 336 nosocomial measles outbreaks according to the data from 1521 ‘Reports of epidemiological investigation of measles cases…’ registered between 2011 and 2019. We performed operational and retrospective epidemiological analysis, as well as evaluation and descriptive analysis. Results. Our retrospective analysis demonstrated that nosocomial measles outbreaks were registered every year with the number of reported cases ranging from 7 (in 2011) to 105 (in 2018). Most frequently, outbreaks were registered in infectious disease hospitals (32%) and departments for infectious diseases in multidisciplinary hospitals among patients with acute respiratory viral infections (28.1%). Less frequently, measles was diagnosed among patients treated in other hospital departments, dispensaries (18.6%), admission departments (11.8%), and polyclinics (9.5%). The factors that contributed to the emergence of nosocomial measles outbreaks included no alertness for measles among doctors and poor epidemic prevention and control in hospitals. Conclusion. To reduce the incidence of nosocomial measles, it is necessary to ensure that patients admitted to hospitals (nonemergency hospitalization) and caregivers have information about measles vaccinations. It is also important to increase the vaccination coverage among healthcare professionals and promote compliance with sanitary and epidemiological control measures in hospitals. Key words: vaccination, nosocomial outbreaks, measles

Relevance. The socio-economic significance of mumps is determined by complications after a previous infection, affecting reproductive function, what entails economic and demographic losses. An important problem today remains the fact that despite high coverage with preventive vaccinations outbreaks of mumps are recorded among children and young adults. Aim. Analyze the epidemic situation with epidemic parotitis in the world according to various literary sources and evaluate measures to control and combat this infection. Conclusions. Outbreaks of mumps have been reported among religious and ethnic groups. Outbreaks were often recorded in organized student and military groups, mainly among persons twice vaccinated. The most affected by the mumps virus were adolescents and young adults, mostly males. Several researchers have shown the possibility of using a third dose of MMR vaccine to control an outbreak, but its short-term effect does not provide conclusive evidence for rethinking two-dose mumps immunization.

To confirm a progress towards the rubella elimination, immunization coverage indicators and the results of serological studies are used. At the same time, the most objective method of assessing collective immunity is a serological examination. The purpose of this work was to compare the results of assessing state of population immunity against rubella virus in the Republic of Belarus and the Russian Federation using various vaccines and different approaches to study organization and cohort selection screening and monitoring. 2019 laboratory studies to determine IgG antibodies against rubella virus were carried out by ELISA method of the unified enzyme immunoassay system Ecolab (Russia). The serum study results of 701 subjects aged 245 years from all the 7 regions of the Republic of Belarus (screening study) and 55 082 subjects aged 349 years (monitoring) from 85 regions of the Russian Federation were analyzed. The results were evaluated in three age groups children, adults, total cohort by using a threshold level of 8385% seropositive individuals sufficient to prevent virus transmission. The antigenic composition of the rubella component in the mono- and complex vaccines respectively used in the Russian Federation and the Republic of Belarus is identical, which allows to compare the state of population immunity against rubella virus therein without taking into account an influence of the vaccine strain. Studies have shown that while using varying vaccine preparations and approaches to organization of serological examination, both in the Republic of Belarus and the Russian Federation, rubella virus-specific IgG level was detected at rather high level in all age groups comprising more than 90%. The portion of rubella seropositive subjects in entire country was 95.44% in the Republic of Belarus and 97.14% in the Russian Federation. Moreover, the level of specific antibodies remains high, despite the low incidence rate and absence of booster effect in both countries. The mean group antibody concentration in seropositive patients in all age groups was quite high and exceeded the minimum protective concentration (11 IU/ml) by 10 or more times. The data obtained indicate the legitimacy of using a serological study of collective rubella immunity as a routine or seromonitoring as well as periodic or screening investigation.

No abstract